Neuropathological alterations in Alzheimer disease - Test2 - elhamkhani - TriplyDB

Neuropathological alterations in Alzheimer disease

Neuropathological alterations in Alzheimer disease

http://www.wikidata.org/entity/Q27003314

about

Ketogenic diet in neuromuscular and neurodegenerative diseases Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid life Untangling tau imaging Olfactory Receptors in Non-Chemosensory Organs: The Nervous System in Health and Disease Intracellular Calcium Dysregulation: Implications for Alzheimer's Disease Somatic mutations in disorders with disrupted brain connectivity Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview An overview on therapeutics attenuating amyloid β level in Alzheimer's disease: targeting neurotransmission, inflammation, oxidative stress and enhanced cholesterol levels Killing Me Softly: Connotations to Unfolded Protein Response and Oxidative Stress in Alzheimer's Disease Amyloid-β and Astrocytes Interplay in Amyloid-β Related Disorders The Therapeutic Potential of Rosemary (Rosmarinus officinalis) Diterpenes for Alzheimer's Disease Epigenetic Alterations in Alzheimer's Disease Involvement of Kallikrein-Related Peptidases in Normal and Pathologic Processes Tau Oligomers: The Toxic Player at Synapses in Alzheimer's Disease Tau missorting and spastin-induced microtubule disruption in neurodegeneration: Alzheimer Disease and Hereditary Spastic Paraplegia Dissecting Alzheimer disease in Down syndrome using mouse models Friends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative Diseases Neurodegeneration and microtubule dynamics: death by a thousand cuts The Role of Inflammatory Mediators in the Pathogenesis of Alzheimer's Disease Misframed ubiquitin and impaired protein quality control: an early event in Alzheimer's disease Alzheimer's Disease associated with Psychiatric Comorbidities A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome Regulation of protein homeostasis in neurodegenerative diseases: the role of coding and non-coding genes Metabolic Risk Factors of Sporadic Alzheimer's Disease: Implications in the Pathology, Pathogenesis and Treatment Mitochondrial Dysfunction Contributes to the Pathogenesis of Alzheimer's Disease Role of P2X7 and P2Y2 receptors on α-secretase-dependent APP processing: Control of amyloid plaques formation "in vivo" by P2X7 receptor Chronochemistry in neurodegeneration Protein prenylation and synaptic plasticity: implications for Alzheimer's disease Behavioral assays with mouse models of Alzheimer's disease: practical considerations and guidelines.Mitochondria-Targeted Protective Compounds in Parkinson's and Alzheimer's Diseases Epidemiology of Alzheimer disease Mitochondrial oxidative stress in aging and healthspan Entorhinal cortical defects in Tg2576 mice are present as early as 2-4 months of age.Passive immunization with phospho-tau antibodies reduces tau pathology and functional deficits in two distinct mouse tauopathy models Gulf War agent exposure causes impairment of long-term memory formation and neuropathological changes in a mouse model of Gulf War Illness 3D Visualization of the Temporal and Spatial Spread of Tau Pathology Reveals Extensive Sites of Tau Accumulation Associated with Neuronal Loss and Recognition Memory Deficit in Aged Tau Transgenic Mice Why looking at the whole hippocampus is not enough-a critical role for anteroposterior axis, subfield and activation analyses to enhance predictive value of hippocampal changes for Alzheimer's disease diagnosis.Potential Links between Impaired One-Carbon Metabolism Due to Polymorphisms, Inadequate B-Vitamin Status, and the Development of Alzheimer's Disease Neuropsychiatric Disturbances in Alzheimer's Disease: What Have We Learned from Neuropathological Studies?Three dimensions of the amyloid hypothesis: time, space and 'wingmen'

P2860

Q21284703-4B32B259-742F-4CE1-9060-5B01F3CB35BC Q24186855-5BF0860B-454C-4871-A3DA-22204560E9CC Q26739091-013F15A7-36DB-482E-83C4-DD35089D9C80 Q26741605-AFB0EAC0-8526-4955-ADAA-29D369B537B5 Q26747203-F6A24998-C5F9-40EB-BEBE-1D0773C0A987 Q26747309-27275B80-693E-4D22-AF34-18A974A0BEB9 Q26750581-C010AB9F-8A8A-4A03-A954-912529959F1A Q26751302-E82C4574-10F6-4F2A-BCC7-E339D16805F0 Q26765824-F9DA65B1-68E5-4A52-83CB-04719A58D194 Q26766934-DBBD1D27-E648-4FF0-9102-A662A1D5E971 Q26768487-EC7DF81D-4377-4263-837A-42FFA90FD4A1 Q26770475-3488A425-714C-4C61-89F0-C64C5D81A4C8 Q26771266-BFA19C3B-34C0-4860-BA17-2CB6F585F834 Q26773154-A1078400-FC6A-4A42-9A0A-E9BF94F189A8 Q26774045-BC0B5C00-B202-47F8-9312-05C3C1581356 Q26777254-738F7451-DAE8-43F3-96BF-CAB9C22CECC9 Q26779933-2F85C22D-E5F3-48C3-9EF4-20B21BE56A54 Q26781649-DF18FA03-71C0-4D7E-A88C-0E2A0ACC35E7 Q26781815-50853620-1065-45A2-A100-CB78026E0066 Q26782999-6F43750C-A443-4987-B188-E4617C74279B Q26796602-C952CD02-CD2B-47E4-B8E4-3485B4588E26 Q26798983-B8E4DF12-D82C-425E-9AE5-64E74E72A652 Q26799208-C41BC80A-68A7-409D-AA9C-9CBF4C87B654 Q26799893-AE438F16-1E31-4805-A072-BA5C005B5A99 Q26801929-9CE7AE9B-803A-410F-92B5-3E3CA1886866 Q26824248-38FD748B-ABB7-49E7-B0A3-DF6F6AE038D3 Q26830057-CEB7FF6D-44C0-45FB-B423-FD180A2FDA6C Q26858942-6CA1A254-E9E6-40A3-B1BD-7C88EBC153CC Q26858963-C01CA108-C320-4492-A5A6-36EB719EC6B7 Q26859141-494862CD-8B4A-449C-98D6-08DEE390D845 Q26865371-6EC0766C-60B3-4CBA-BD7A-CE677477A7FD Q27025099-880E51AB-C10E-4BBA-98B8-35E2D96568A2 Q27307826-76067615-50C1-4962-94AE-04FC4FE3FA05 Q27308146-BC59ADB1-EF2F-4AE7-8748-5504BBD06CC1 Q27312033-F4DD04C2-21A7-43E3-B866-026D3C66E0B6 Q27334236-12779375-0DD2-434C-9E91-9919F52D6691 Q27692592-3ACB7090-C898-42B0-8941-7ABF5AF7B3C4 Q28068353-162B6372-B3EC-4B8C-AE1A-3EBE2FFE32A4 Q28070156-FCF2A85E-0B13-430E-AD41-363E4DE0E3CD Q28082768-91B99D89-CAAF-4466-B33D-D20483CB9253

P2860

Neuropathological alterations in Alzheimer disease

http://www.wikidata.org/entity/Q27003314

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Neuropathological alterations in Alzheimer disease

@ast

Neuropathological alterations in Alzheimer disease

@en

Neuropathological alterations in Alzheimer disease

@nl

type

label

Neuropathological alterations in Alzheimer disease

@ast

Neuropathological alterations in Alzheimer disease

@en

Neuropathological alterations in Alzheimer disease

@nl

prefLabel

Neuropathological alterations in Alzheimer disease

@ast

Neuropathological alterations in Alzheimer disease

@en

Neuropathological alterations in Alzheimer disease

@nl

P1433

Q27003314-7DBE361E-A9C5-4C7D-9F8F-AFB7A50D1F4B

P1476

Q27003314-4801A13A-3F1D-4C49-BE2A-21BA96F1A678

P2093

Q27003314-6D5902EF-213B-43B2-A2EF-F1AF87EBE7E7

Q27003314-790F95BC-8824-41F6-BC57-A34355F5C9A6

Q27003314-BEE1D542-8F8D-4661-A3A7-1F145FB215C6

Q27003314-F9B20A51-1151-4555-B02A-EC135E80DEE8

P2860

Q27003314-01C1D2BA-E5CB-4273-A00B-A14974801D4F

Q27003314-021DB66F-023C-47FE-A5EA-7A590A60B7BC

Q27003314-022D0C4F-13F9-4349-9DE2-AE6078F93DAF

Q27003314-04D7F78F-118D-412C-BCFF-DC28E8A5C68F

Q27003314-05462E26-9227-4E93-9A5C-C667EE83AAE4

Q27003314-06BD73AC-0DEA-4995-A86A-5C0E1F702B1C

Q27003314-081E0CB0-A6C7-4E74-B48C-6FC8E92C3B3D

Q27003314-08747133-1CC1-4DA6-B9B3-344990A4C4C9

Q27003314-08FC44F6-6903-4D57-AA8E-C6F6C291AC4F

Q27003314-0A187352-F154-4007-8F9E-ACF0FAA3928D

P304

Q27003314-B8EFD024-7ADF-4A33-993D-083FD2F823F8

P31

Q27003314-D34AFE4B-F122-4CB2-B90E-BD60C31307F4

P3181

Q27003314-6DB90560-AB0D-4548-858A-35FD6F4B5735

P356

Q27003314-B455B5E4-F28C-48A0-B7CD-4A4EB63F99D0

P407

Q27003314-4BA43EA1-FA57-46B5-A196-628D0B8DF35C

P433

Q27003314-12AFD476-D24C-4BE4-AFCF-7B22375BCF95

P478

Q27003314-24F44205-9E56-4A55-9789-097D181556B6

P577

Q27003314-82BF82F0-F24E-49EE-97B3-013BE4DCCA4A

P5875

Q27003314-46D9479C-1606-4463-8D20-34A05729F6BA

P698

Q27003314-6EFC2F9B-952D-47E6-8ACA-D365CCA34917

P921

Q27003314-DDA4AC6A-BA0C-42D4-9D46-027FEC335BF4

P932

Q27003314-C4A4B6EB-DE1A-4275-BF58-E9738DE84DD1

P3181

P356

CSHPERSPECT.A006189

P1433

Cold Spring Harbor Perspectives in Medicine

P1476

Neuropathological alterations in Alzheimer disease

@en

P2093

A. Serrano-Pozo

http://www.w3.org/2001/XMLSchema#string

B. T. Hyman

http://www.w3.org/2001/XMLSchema#string

E. Masliah

http://www.w3.org/2001/XMLSchema#string

M. P. Frosch

http://www.w3.org/2001/XMLSchema#string

P2860

A Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer's Disease

Progressive accumulation of amyloid-beta oligomers in Alzheimer's disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins

Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein

Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior

Alpha-synuclein in Lewy bodies

Neuropathological stageing of Alzheimer-related changes

Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

P304

a006189

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

415683

http://www.w3.org/2001/XMLSchema#string

P356

10.1101/CSHPERSPECT.A006189

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2011-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51718428

http://www.w3.org/2001/XMLSchema#string

P698

22229116

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3234452

http://www.w3.org/2001/XMLSchema#string